Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2022 Earnings Call Transcript

Page 2 of 2

So we feel that we’ve been tailor made for PASTEUR. It was scratched in favor of a defense spending bill about six months ago at the last minute, ninth inning. So we’re still hopeful that in the new Congress, it will pass.

Jason McCarthy: Got it. Thanks for taking the questions this morning.

David Luci: No problem. Thank you, Jason.

Operator: . There are no further questions at this time. This concludes today’s teleconference call. You may disconnect your line and have a great day. Thank you for your participation.

David Luci: Thank you, Victoria.

Robert Shawah: Thank you.

Follow Acurx Pharmaceuticals Inc.

Page 2 of 2